Doximity, Inc.
DOCS
$63.98
-$1.98-3.00%
| Weiss Ratings | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | B+ | |||
| Rating Factors | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.05 | |||
| Price History | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -12.24% | |||
| 30-Day Total Return | 14.93% | |||
| 60-Day Total Return | 15.22% | |||
| 90-Day Total Return | 54.28% | |||
| Year to Date Total Return | 19.45% | |||
| 1-Year Total Return | 123.00% | |||
| 2-Year Total Return | 90.81% | |||
| 3-Year Total Return | 22.36% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -22.59% | |||
| 52-Week Low % Change | 187.28% | |||
| Price | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $85.21 | |||
| 52-Week Low Price | $22.96 | |||
| 52-Week Low Price (Date) | May 13, 2024 | |||
| 52-Week High Price (Date) | Feb 10, 2025 | |||
| Valuation | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 12.38B | |||
| Enterprise Value | 11.54B | |||
| Price/Earnings (TTM) | 65.92 | |||
| Earnings Per Share (TTM) | 1.00 | |||
| Earnings Per Share Growth | 49.32% | |||
| Price/Earnings To Growth | 1.34 | |||
| Price/Sales (TTM) | 24.25 | |||
| Price/Book (Q) | 12.00 | |||
| Enterprise Value/Revenue (TTM) | 20.98 | |||
| Price | $63.98 | |||
| Enterprise Value/EBITDA (TTM) | 50.45 | |||
| Enterprise Value/EBIT | 51.54 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 202.23M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 549 4330 | |||
| Address | 500 3rd Street San Francisco, CA 94107 | |||
| Website | www.doximity.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 40.70% | |||
| Profit Margin | 36.59% | |||
| Management Effectiveness | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 12.88% | |||
| Return on Equity | 21.24% | |||
| Income Statement | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 550.17M | |||
| Total Revenue (TTM) | 550.17M | |||
| Revenue Per Share | $2.72 | |||
| Gross Profit (TTM) | 496.19M | |||
| EBITDA (TTM) | 228.85M | |||
| EBIT (TTM) | 223.97M | |||
| Net Income (TTM) | 201.35M | |||
| Net Income Avl. to Common (TTM) | 201.35M | |||
| Total Revenue Growth (Q YOY) | 24.63% | |||
| Earnings Growth (Q YOY) | 56.80% | |||
| EPS Diluted (TTM) | 1.00 | |||
| EPS Diluted Growth (Q YOY) | 54.17% | |||
| Balance Sheet | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 844.94M | |||
| Cash Per Share (Q) | $4.18 | |||
| Total Current Assets (Q) | 1.01B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.03B | |||
| Current Ratio (Q) | 8.739 | |||
| Book Value Per Share (Q) | $5.50 | |||
| Total Assets (Q) | 1.17B | |||
| Total Current Liabilities (Q) | 115.88M | |||
| Total Debt (Q) | 12.95M | |||
| Total Liabilities (Q) | 141.04M | |||
| Total Common Equity (Q) | 1.03B | |||
| Cash Flow | DOCS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -81.00M | |||
| Cash from Financing (TTM) | -115.55M | |||
| Net Change in Cash (TTM) | 42.18M | |||
| Levered Free Cash Flow (TTM) | 189.25M | |||
| Cash from Operations (TTM) | 238.72M | |||
